Literature DB >> 3757152

A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide.

G Molineux, C Xu, J Hendry, N G Testa.   

Abstract

Following repeated treatment of mice with cyclophosphamide (5 X 200 mg/kg) it was found that slight, but significant, residual marrow damage persisted for at least half the lifespan of the animals. This long-term damage occurred despite preferential sparing of those multi-potential haematopoietic cells (CFU-S) that had a high self-renewal capacity after each step of the multistep regimen and despite a smaller CFU-S kill after each successive dose. The damage was characterized by low mean numbers of CFU-S and stromal colony-forming cells (CFU-F) which were around 70% of control values. Examination of individual animals revealed that the majority had slightly subnormal numbers of CFU-S and CFU-F, with only a few suffering a more severe injury, including 8% of mice with clinical hypoplasia or myelodysplasia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757152     DOI: 10.1007/bf00253055

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  26 in total

1.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

2.  Screening of cytotoxic drugs for residual bone marrow damage.

Authors:  K J Trainor; A A Morley
Journal:  J Natl Cancer Inst       Date:  1976-12       Impact factor: 13.506

3.  Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity.

Authors:  W D DeWys; A Goldin; N El
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

4.  Effect of two cyclophosphamide derivatives on hemopoietic progenitor cells and pluripotential stem cells.

Authors:  A Porcellini; A Manna; N Talevi; G Sparaventi; M T Marchetti-Rossi; D Baronciani; M De Biagi
Journal:  Exp Hematol       Date:  1984-12       Impact factor: 3.084

5.  Effects of chemotherapeutic agents on hemopoietic stromal tissue: I. Effects of cyclophosphamide and bleomycin on hemopoiesis in subcutaneous femur implants.

Authors:  S S Adler; R D Kuznetsky
Journal:  Exp Hematol       Date:  1984-03       Impact factor: 3.084

6.  A cellular analysis of residual hemopoietic deficiencies in mice after 4 repeated doses of 4.5 Gray X rays.

Authors:  J H Hendry; C X Xu; N G Testa
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-11       Impact factor: 7.038

7.  Suppression of marrow stromal cells and microenvironmental damage following sequential radiation and cyclophosphamide.

Authors:  L M Wathen; S A Knapp; R L DeGowin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-07       Impact factor: 7.038

8.  An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan.

Authors:  A Morley; J Blake
Journal:  Blood       Date:  1974-07       Impact factor: 22.113

9.  Decreased plasma half-life of cyclophosphamide during repeated high-dose administration.

Authors:  M I Graham; I C Shaw; R L Souhami; B Sidau; P G Harper; A E McLean
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

10.  Long-term bone-marrow damage in children treated for ALL: evidence from in vitro colony assays (GM-CFC and CFUF).

Authors:  C Haworth; P H Morris-Jones; N G Testa
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

View more
  4 in total

1.  Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation.

Authors:  C Twelves; R Souhami; P Harper; A Goldstone
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice.

Authors:  R A Pecyk; E B Fraser-Smith; T R Matthews
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

3.  Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide.

Authors:  E Marshall; L B Woolford; B I Lord
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 4.  Long-term hematopoietic damage: concepts, approaches, and results relevant to the study of environmental toxins.

Authors:  N G Testa; T M Dexter
Journal:  Environ Health Perspect       Date:  1989-07       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.